Quintiles IMS Holdings Inc to Post Q1 2018 Earnings of $1.18 Per Share, William Blair Forecasts (Q)

Quintiles IMS Holdings Inc (NYSE:Q) – Analysts at William Blair issued their Q1 2018 earnings estimates for shares of Quintiles IMS Holdings in a research note issued to investors on Thursday. William Blair analyst J. Kreger forecasts that the medical research company will earn $1.18 per share for the quarter. William Blair has a “Outperform” rating and a $93.42 price target on the stock. William Blair also issued estimates for Quintiles IMS Holdings’ Q2 2018 earnings at $1.25 EPS, Q3 2018 earnings at $1.34 EPS and Q4 2018 earnings at $1.54 EPS.

Quintiles IMS Holdings (NYSE:Q) last posted its earnings results on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, topping the consensus estimate of $1.14 by $0.05. The company had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $2.01 billion. Quintiles IMS Holdings had a net margin of 3.45% and a return on equity of 4.55%. The firm’s revenue for the quarter was up 77.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.00 earnings per share. TRADEMARK VIOLATION WARNING: “Quintiles IMS Holdings Inc to Post Q1 2018 Earnings of $1.18 Per Share, William Blair Forecasts (Q)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/27/quintiles-ims-holdings-inc-to-post-q1-2018-earnings-of-1-18-per-share-william-blair-forecasts-q.html.

Other research analysts have also issued reports about the stock. Argus increased their price target on shares of Quintiles IMS Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a research note on Monday, September 18th. KeyCorp reiterated a “buy” rating and issued a $100.00 price target on shares of Quintiles IMS Holdings in a research note on Sunday, September 24th. BidaskClub lowered shares of Quintiles IMS Holdings from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 11th. Zacks Investment Research upgraded shares of Quintiles IMS Holdings from a “hold” rating to a “buy” rating and set a $101.00 price target for the company in a research note on Thursday, July 27th. Finally, Barclays PLC set a $100.00 price target on shares of Quintiles IMS Holdings and gave the stock a “buy” rating in a research note on Friday, August 4th. Ten equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $97.88.

Quintiles IMS Holdings (Q) traded up 1.45% during midday trading on Friday, hitting $107.03. 1,710,439 shares of the stock traded hands. The stock’s 50-day moving average price is $97.06 and its 200-day moving average price is $90.20. Quintiles IMS Holdings has a 52 week low of $70.10 and a 52 week high of $108.43. The stock has a market capitalization of $23.17 billion, a P/E ratio of 310.23 and a beta of 0.62.

In other news, insider Ari Bousbib sold 92,160 shares of the firm’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now owns 1,082,919 shares of the company’s stock, valued at approximately $97,841,731.65. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Kevin C. Knightly sold 19,339 shares of the firm’s stock in a transaction dated Friday, August 25th. The shares were sold at an average price of $99.51, for a total transaction of $1,924,423.89. Following the sale, the insider now directly owns 40,650 shares in the company, valued at approximately $4,045,081.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,208,382 shares of company stock worth $1,362,839,475. Insiders own 6.40% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. ProShare Advisors LLC boosted its holdings in shares of Quintiles IMS Holdings by 2.5% during the 2nd quarter. ProShare Advisors LLC now owns 2,920 shares of the medical research company’s stock valued at $261,000 after acquiring an additional 71 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in shares of Quintiles IMS Holdings by 0.7% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 11,315 shares of the medical research company’s stock valued at $1,013,000 after acquiring an additional 84 shares during the last quarter. Bbva Compass Bancshares Inc. boosted its holdings in shares of Quintiles IMS Holdings by 4.2% during the 2nd quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock valued at $197,000 after acquiring an additional 88 shares during the last quarter. Cutter & CO Brokerage Inc. boosted its holdings in shares of Quintiles IMS Holdings by 4.2% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,805 shares of the medical research company’s stock valued at $341,000 after acquiring an additional 152 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Quintiles IMS Holdings by 4.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 4,484 shares of the medical research company’s stock valued at $401,000 after acquiring an additional 171 shares during the last quarter. 93.27% of the stock is currently owned by hedge funds and other institutional investors.

About Quintiles IMS Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles IMS Holdings (NYSE:Q)

Receive News & Ratings for Quintiles IMS Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles IMS Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply